entertainment -WSS

entertainment

author：focus 2025-09-03 14:37:02 - browse：692

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Wikipedia

WSS

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

What we’ve learned from the Aduhelm mess

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

As the dark side of IVF slowly comes into focus, even more transparency is needed

Gilead might be held responsible for not developing a drug

Readout LOUD podcast: How biotech is using artificial intelligence

entertainment

entertainment

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

For Medicare Advantage, Democrats want stronger protections around AI

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

BioMarin wins approval for gene therapy to treat hemophilia A

Behind warning on Apellis’s eye drug lies a conflict of interest

Wildfire smoke exposes gaps in outdoor worker protections

Will biotech layoffs continue through 2023?

United colonoscopy coverage change 'may cost lives,' doctors say

Interest rates are at a 22

explore

Ending health disparities requires full federal government, panel says

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Robert F. Kennedy is pitching centrism on health, even on abortion

What we’ve learned from the Aduhelm mess

Medical mystery: When a cough is not just a cough

Ending health disparities requires full federal government, panel says

focus

Wikipedia

explore

explore